Where Global Innovation
and Capital Meet
LIVE

Deals

Deals: May 17, 2022

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.


May 17, 2022

Deal net: May 16, 2022

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

May 16, 2022

Deals: April 25, 2022

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Apr 25, 2022

Octant Bio accepts $80m

The small molecule drug developer, co-founded by a UCLA associate professor, has completed its series B round.

Apr 21, 2022

Deals: April 13, 2022

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Apr 13, 2022

Aurion Biotech advances with $120m

Exploiting research conducted at Kyoto Prefecture University of Medicine, Aurion Biotech is focusing on therapies that can restore vision.

Apr 13, 2022

Exits: April 12, 2022

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Apr 12, 2022

Deals: April 12, 2022

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Apr 12, 2022

News Continued

Improbable imports $150m in funding

The metaverse technology developer has now pushed its overall funding past $750m since emerging out of Cambridge’s Department of Computer Science and Technology.

Apr 12, 2022

Deal net: April 8, 2022

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Apr 8, 2022

Microba makes tracks to ASX

The gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.

Apr 7, 2022

Climeworks clasps $646m

The round which pushed the ETH Zurich-linked carbon capture system developer's overall financing past the $800m mark.

Apr 7, 2022

Retro looks ahead with $180m

The company, which largely remains in stealth mode, has set itself a mission of increasing the human lifespan by a decade.

Apr 7, 2022

Deals: April 7, 2022

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Apr 7, 2022

Editor's Picks

CFS sparks $1.8bn series B

MIT spinout Commonwealth Fusion Systems has raised the largest funding round yet for a nuclear fusion developer with investors including The Engine.

Dec 1, 2021

Aerovate accesses public markets

Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.

Jul 1, 2021

Big deal: Oxford PV begins capturing series D

Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.

Mar 18, 2019

Big deal: Ribon ties together $65m series B

Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.

Jan 7, 2019
© 2021 Mawsonia Ltd. All rights reserved.
test reg

Login